Atara Biotherapeutics Inc Stock Ownership - Who owns Atara Biotherapeutics?

Insider buying vs selling

Have Atara Biotherapeutics Inc insiders been buying or selling?
Eric J. HyllengrenEVP CFO2024-05-1628,648$0.62
Anhco NguyenEVP Chief Sci. Tech Officer2024-05-1642,899$0.62
Amar MuruganEVP Chief Legal Officer2024-05-1632,401$0.62
Pascal TouchonPresident and CEO2024-05-1681,506$0.62
Jill HenrichEVP Global Head RA Quality2024-05-1625,750$0.62
Pascal TouchonPresident and CEO2024-03-0424,844$0.72
Amar MuruganEVP Chief Legal Officer2024-03-0410,044$0.72
Eric J. HyllengrenEVP CFO2024-03-045,217$0.72
Eric J. HyllengrenEVP CFO2024-03-041,462$0.72
Jill HenrichEVP Global Head RA Quality2024-03-043,879$0.72

1 of 4

ATRA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ATRA insiders and whales buy or sell their stock.

ATRA Shareholders

What type of owners hold Atara Biotherapeutics Inc stock?
Ecor1 Capital LLC8.44%10,167,043$5.31MInstitution
Redmile Group LLC7.69%9,263,309$4.84MInstitution
Blackrock Inc5.67%6,831,479$3.57MInstitution
Bank Of America Corp5.46%6,580,577$3.44MInstitution
Citadel Advisors LLC5.41%6,512,063$3.40MInstitution
Vanguard Group Inc4.16%5,012,938$2.62MInstitution
Price T Rowe Associates Inc4.12%4,958,150$2.59MInstitution
Boxer Capital LLC3.45%4,150,000$2.17MInstitution
Vestal Point Capital LP2.33%2,800,000$1.46MInstitution
Acadian Asset Management LLC2.19%2,638,687$1.38MInstitution

1 of 3

ATRA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATRA69.16%10.86%Net BuyingNet Selling
CSBR1.91%98.09%Net Buying
INTS11.91%14.63%Net BuyingNet Buying
PASG49.60%50.40%Net Buying

Atara Biotherapeutics Stock Ownership FAQ

Who owns Atara Biotherapeutics?

Atara Biotherapeutics (NASDAQ: ATRA) is owned by 69.16% institutional shareholders, 10.86% Atara Biotherapeutics insiders, and 19.99% retail investors. Domain Partners Viii LP is the largest individual Atara Biotherapeutics shareholder, owning 2.14M shares representing 1.78% of the company. Domain Partners Viii LP's Atara Biotherapeutics shares are currently valued at $1.20M.

If you're new to stock investing, here's how to buy Atara Biotherapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.